---
title: "R&G Pharma (301333.SZ) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/301333.SZ/norm.md"
symbol: "301333.SZ"
name: "R&G Pharma"
parent: "https://longbridge.com/zh-HK/quote/301333.SZ.md"
datetime: "2026-03-13T11:01:09.097Z"
locales:
  - [en](https://longbridge.com/en/quote/301333.SZ/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301333.SZ/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301333.SZ/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/301333.SZ/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/301333.SZ/norm.md)


# R&G Pharma (301333.SZ) — 財務報表

## 損益表 (CNY)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.3599 | 0.3711 | 0.2700 | 0.5951 | 0.2700 |
| ROE | 7.24% | 7.47% | 5.64% | 12.34% | 5.77% |
| Revenue | 227.71M | 206.82M | 172.84M | 182.08M | 182.93M |
| Net income | 34.45M | 35.04M | 26.07M | 55.80M | 25.91M |
| Operating income | 36.55M | 33.88M | 23.01M | 44.59M | 25.36M |
| Gross margin | 32.74% | 38.00% | 36.53% | 30.60% | 37.35% |
| Net margin | 15.13% | 16.94% | 15.09% | 30.65% | 14.16% |
| Profit quality | -2944.70% | 72.29% | -205.61% | 90.35% | 57.19% |

## 資產負債表 (CNY)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 2.32B | 2.31B | 2.28B | 2.34B | 2.30B |
| Leverage | 1.21 | 1.22 | 1.22 | 1.27 | 1.29 |
| BVPS | 20.19 | 19.84 | 19.59 | 19.26 | 18.88 |
| Turnover | 0.3418 | 0.3271 | 0.3292 | 0.3374 | 0.3519 |
| Cash & STI | 1.72B | 1.72B | 1.71B | 1.78B | 1.74B |
| Inv & Rec | 77.83M | 70.33M | 70.43M | 65.23M | 63.46M |
| LT assets | 55.21M | 53.76M | 53.23M | 55.58M | 60.18M |
| Net debt | -1.71B | -1.70B | -1.70B | -1.70B | -1.64B |

## 現金流量表 (CNY)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -1.24M | 46.87M | -11.19M | 49.36M | 44.35M |
| Investing CF | -100.82M | 93.87M | -241.50M | 335.97M | 147.94M |
| Financing CF | -9.58M | -7.07M | -45.42M | -10.74M | -24.68M |
| Free CF | -37.72M | 48.84M | -28.28M | 87.68M | -62.09M |
| OCF coverage | -32.57% | 337.25% | -18.70% | 155.84% | 296.93% |
| Repaid & issued | - | - | - | 0.0000 | 54.79M |
| CapEx | -6.01M | -5.81M | -4.71M | -7.50M | -3.59M |

## 分紅方案

**股息率**: 0.24

### 分紅歷史

| 描述 | 登記日 | 除息日 | 付息日 |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.158383CNY | 2025-07-07 | 2025-07-08 | 2025-07-08 |
| Cash Dividend: 
0.2CNY | 2024-07-04 | 2024-07-05 | 2024-07-05 |
| Cash Dividend: 
0.25CNY. 
Share conversation: 0.6 for 1 | 2023-06-28 | 2023-06-29 | 2023-06-29 |